PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33497736-12	2021	The results of PPI network and molecular docking showed that EGFR, BRAF and AKT1 were the key targets of Scopoletin against NSCLC, which were consistent with the western-blot results.	Scopoletin	105-115	AKT serine/threonine kinase 1	Homo sapiens	76-80	
33497736-13	2021	SIGNIFICANCE: Through network pharmacology, molecular docking and experiments in vitro, Scopoletin was verified to against NSCLC through RAS-RAF-MEK-ERK pathway and PI3K/AKT pathway.	Scopoletin	88-98	AKT serine/threonine kinase 1	Homo sapiens	170-173